Healthcare

An app improves the support for and monitoring of patients with aortic valve stenosis

The Programme for the Integral, Transversal and Multidisciplinary Management of Aortic Valve Stenosis (MITMEVA) has already ensured that 15 patients with aortic valve stenosis, who have undergone TAVI or valve replacement surgery, have completed medical follow-up and received healthy lifestyle advice using the CAARING app.  

The main aim of this proposal is to improve the quality and efficiency of the clinical management of patients with Aortic Valve Stenosis

The monitoring process provided by the MITMEVA programme app allows patients to receive daily communications on their mobile phone before the operation. These communications include information on the disease, advice on diet, physical and respiratory prehabilitation exercises, on what will happen when they are admitted to hospital, and information on the TAVI or surgical procedure, which we hope will have a positive impact on reducing anxiety and on their post-operative physical recovery.  

At the same time, and after the operation, the patients continue to be monitored constantly and receive daily communications to look out for any possible complications and to detect them early. The app is connected to the Hospital Clínic’s professionals at all times. They have first-hand knowledge of each patient's case and can intervene if necessary. Similarly, the patient continues to receive dietary and physical rehabilitation advice during the first two months after the operation. The app was designed by and is implemented by Medtronic Inc.  

The team from the Hospital Clínic Cardiovascular Institute manages the Programme for the Integral, Transversal and Multidisciplinary Management of Aortic Valve Stenosis (MITMEVA).  It is a Public Procurement of Innovation (CPI) programme promoted by the Department of Health with funding from the European Regional Development Fund (ERDF). 

The main aim of this proposal is to improve the quality and efficiency of the clinical management of patients with Aortic Valve Stenosis (AVS), candidates for aortic valve replacement by surgical or percutaneous means (TAVI) or for palliative treatment.  This programme is also designed to optimize the available resources with a new integral, transversal and multidisciplinary healthcare model (MITMEVA).